SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Check Before You Invest : Fischer Medical Ventures Ltd

BSE: 524743 NSE: FISCHER ISIN: INE771F01041
  |   Sector:  Miscellaneous   |   Industry:  Trading

Snapshot

Q.1 Which industry/sub-sector does Fischer Medical Ventures Ltd belong to?
Fischer Medical Ventures Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.2 Is Fischer Medical Ventures Ltd a good quality company?
Fischer Medical Ventures Ltd is a weak quality company, based on a inconsistent 5-year financial track record.
Q.3 Is Fischer Medical Ventures Ltd undervalued or overvalued?
Fischer Medical Ventures Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Fischer Medical Ventures Ltd a good buy now?
Fischer Medical Ventures Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Return on capital employed (ROCE) of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Return on capital employed is 0.53% for FY-2025, which is in line with its 5-year historical median of 0.53%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 13.5%, indicating value preservation.
Q.2 Return on Asset of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Return on Asset is 0.29%, which is in line with its 5-year historical median of 0.29%, indicating stable asset utilization efficiency.
Q.3 Gross Profit margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Gross profit margin which is the profit after deduction of direct costs, is 20.8% for FY-2025, which is above its 5-year median of -0.7%, indicating increasing margins.
Q.4 Operating Profit Margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -42.86% for FY-2025, which is below its 5-year median of -10.67% indicating decreasing margins.
Q.5 Net Profit Margin of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Net Profit Margin is 12.71% for FY-2025, is above with its 5-year median of 3.49%, indicating increasing margins.
Current Level 5-year
Historic Median
Gross Profit Margin 20.8 -0.7
Operating Profit Margin -42.86 -10.67
Net Profit Margin 12.71 3.49
Q.6 Debt to Equity ratio of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.17, indicating lower debt levels in the industry.
Q.7 Debt to cash flow from operations of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Fischer Medical Ventures Ltd?
Promoters hold 62.15% of the Fischer Medical Ventures Ltd, with 7.38% of their stake pledged, indicating low pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Fischer Medical Ventures Ltd vs industry peers?
Fischer Medical Ventures Ltd revenue CAGR is 96.10%, compared to the industry median CAGR of 12.68%, indicating faster growth and gaining its market share.
Profit Metrics
Current Level 5-year
Industry Median
Revenue Growth - 12.7
Gross Profit Growth - 17.4
Operating Profit Growth 0 16.7
Net Profit Growth 0 17.2
Operating Efficiency
Current Level 5-year
Industry Median
Asset Turnover 0.02 0.81
ROE - 2.6
ROCE 0.53 3.8
Cash Conversion Cycle (days) 635.48 61

Valuation & price assessment

Q.1 Stock return of Fischer Medical Ventures Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 68.6% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price
CAGR
68.6% 72.4% 54.7% -49.7%
Q.3 Valuation ratios of Fischer Medical Ventures Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?
Valuation Ratios Current 5-year
Historic Median
5-year
Industry Median
Price to Earnings - 3.17 33.44
Price to Book 7.86 10.40 1.58
Price to Sales 136.64 295.16 2.20
EV to EBITDA 1065.44 651.57 14.05

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×